韩国医疗保健行业市场前景及投资研究报告-外文版培训课件2024.7temu

CONSUMERS

&

BRANDSHealthcareinSouthKoreaCHAPTER

01GlobaloverviewGlobalhealthspendingpercapitain2019andprojectionfor2050(inU.S.dollars)Estimatedglobalpercapitahealthspending2019&2050Healthspendingperperson(in2020U.S.dollars)Healthspendingperperson(in2020adjusteddollars)2,5002,0001,5001,0005002,0501,5151,4821,1290201920503Description:Totalhealthspendingperpersongloballyin2019averagedtosome1,129U.S.dollars(1,482projectionfor2050(inU.S.dollars).Readmoredollars),andisestimatedtoincreaseto1,515U.S.dollars(2.050dollars)by2050.Thisstatisticshowstheglobalhealthspendingpercapitain2019andNote(s):Worldwide;Datapast2019isforecastedSource(s):IHMEHealthexpenditureasapercentageofgrossdomesticproduct(GDP)inselectedcountriesin2022HealthexpenditureasapercentageofGDPinselectcountries2022Percentageofgrossdomesticproduct6%

8%

10%0%2%4%12%14%16%18%UnitedStatesGermanyFrance16.6%12.7%11.9%JapanAustria11.5%11.4%11.3%11.3%11.2%11.2%11.2%UnitedKingdomSwitzerlandNewZealandNetherlandsCanadaBelgiumSwedenPortugal10.9%10.7%10.6%4Description:AmongOECDmembercountries,theUnitedStateshadthehighestpercentageofgrossdomesticproductspentonhealthcarein2022.TheU.S.spentnearly16percentofitsGDPonhealthcareservices.Germany,FranceandJapanfollowedtheU.S.withdistinctlysmallerpercentages.TheUnitedStateshadbothsignificantlyhigherprivateandpublicspendingonhealthcomparedwithotherdevelopedcountries.ReadmoreNote(s):Worldwide,OECD;2021Source(s):OECDPercapitahealthexpenditureinselectedcountriesin2022(inU.S.dollars)Percapitahealthexpenditureinselectedcountries2022PercapitaexpenditureincurrentPPPsUnitedStatesSwitzerlandGermanyNorway12,555.38,049.18,010.97,898NetherlandsAustria7,357.67,275.4Belgium6,6006,596.56,516.66,437.76,436.1AustraliaFranceSwedenLuxembourgCanada6,3196,279.8Denmark5Description:In2022,theUnitedStateshadthehighestpercapitahealthexpenditureamongOECDcountries.Atthattime,percapitahealthexpenditureintheU.S.amountedto12,555U.S.dollars,significantlyhigherthaninSwitzerland,thecountrywiththesecondhighestpercapitahealthexpenditure.Germany,Norway,andtheNetherlandsarealsowithinthetopfivecountrieswiththehighestpercapitahealthexpenditure.TheUnitedStatesalsospentthehighestshareofit’sgrossdomestic[...]ReadmoreNote(s):Worldwide;2022Source(s):OECDCountrieswiththehighestaveragelifeexpectancyforthosebornin2023,bygender(inyears)Countrieswiththehighestlifeexpectancy2023,bygenderLifeexpectancyinyearsFemales40Males5001020306070809010089MonacoKorea,SouthChina,HongKongSAR*China,MacaoSAR*Japan84878787878781818181SanMarinoSpainMaltaIsraelSingaporeAustralia83838686858082818181858585Liechtenstein6Description:Monacohadthehighestlifeexpectancyamongbothmenandwomenworldwideasof2023.Thatyear,lifeexpectancyformenandwomenwas84and89years,respectively.TheEastAsiancountriesandregionsSouthKorea,HongKong,Macao,andJapanfollowed,allwithrespectivemaleandfemalelifeexpectanciesof81and87years.Manyofthecountriesonthelistarestrugglingwithagingpopulationsandadecliningworkforceasmorepeopleenterretirementagecomparedtopeople[...]

ReadmoreNote(s):Worldwide;2023Source(s):PopulationReferenceBureauCHAPTER

02CostandexpenditureSouthKorea'snationalhealthexpenditureasapercentofGDPfrom2000to2022HealthspendingaspercentofGDPinSouthKorea2000-202211.0%10.0%9.0%8.0%7.0%6.0%5.0%4.0%3.0%2000

2001

2002

2003

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

20228Description:In2022,thetotalhealthexpenditureinSouthKoreaaccountedforapproximately9.7percentofSouthKorea'sGrossDomesticProduct(GDP).Thiswasaslightincreasefromthepreviousyear'sshare,makingitthehighestshareinthepastdecade.Overall,thisshareindicatesthatastheGDPgrew,healthspendinggrewatanevenfasterrate.Korea'sGDPpercapitawasestimatedtohavedroppedtoaround32.3thousandU.S.dollarsin2022,anincreasefromaround19thousanddollarsin[...]

ReadmoreNote(s):SouthKorea;2000to2022Source(s):OECDPharmaceuticalexpenditureasshareoftheGDPofSouthKoreafrom2000to2022PharmaceuticalspendingasshareofGDPSouthKorea2000-20221.9%1.8%1.7%1.6%1.5%1.71%1.68%1.65%1.59%1.51%1.47%1.46%

1.46%1.45%1.44%1.44%1.39%1.39%

1.39%

1.39%1.36%

1.36%1.4%1.3%1.2%1.1%1.0%0.9%1.25%1.22%

1.22%1.14%1.11%0.94%2000

2001

2002

2003

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

20229Description:In2022,pharmaceuticalspendinginSouthKoreaamountedtoaround1.7percentofthetotalGrossDomesticProduct(GDP).Thisrepresentsaslightincreasefromthepreviousyear.PharmaceuticalspendinginrelationtoGDPhasbeenaboveonepercentsincetheyear2001,andhascontinuedtoslowlybutsteadilyincreaseyearbyyear.ReadmoreNote(s):SouthKorea;2000to2022Source(s):OECDTotalmedicalexpenditureinSouthKoreafrom2012to2022(intrillionSouthKoreanwon)TotalmedicalexpenditureSouthKorea2012-202212010080102.4393.586.4886.9577.6669.3464.5857.95604020054.4350.9647.842012201320142015201620172018201920202021202210Description:In2022,thetotalmedicalexpenditureinSouthKoreaamountedtoapproximately102.4trillionSouthKoreanwon.Thisrepresentsanincreasefromthepreviousyear.Totalexpenditurehasincreasedsteadilysince2012,upbyover114percentfromaround47.8trillionwon.ReadmoreNote(s):SouthKorea;2012to2022Source(s):HIRA;NHISAnnualexpenditureonhealthpercapitainSouthKoreafrom2012to2022(in1,000U.S.dollars)SpendingonhealthpercapitaSouthKorea2012-20225.04.54.03.53.04.574.193.593.293.072.792.652.472.52.01.51.00.50.02.212.12.0420122013201420152016201720182019202020212022*11Description:In2022,SouthKoreansspentapproximately4.6thousandU.S.dollarspercapitaonhealth.HealthspendingisdefinedbytheOECDasthecostofhealthcaregoodsandservices.Intheprecedingyear,Koreansspentanaverageof4.2thousanddollars.Withpercapitaspendingsteadilyincreasingoverthepastdecade,ithasnowsurpassedthe2019OECDaverageofoverfourthousanddollars.

ReadmoreNote(s):SouthKorea;2012to2022;*Preliminary.Accordingtothesource,healthspendingmeasuresthefinalconsumptionofhealthcaregoodsandservicesandexcludingexpenditureoninvestments.Figureshavebeenrounded.Thesourcedid[...]

ReadmoreSource(s):OECDPharmaceuticalspendingpercapitainSouthKoreafrom2000to2022inU.S.dollarsPharmaceuticalspendingpercapitainSouthKorea2000-202290080070060050040030020010002000

2001

2002

2003

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

202212Description:In2022,pharmaceuticalspendinginSouthKoreaamountedtoaround803.3U.S.dollarspercapita.Percapitaspendinghasbeenincreasingoverthelasttwodecades,upbyover357.5percentsince2000.Thepreviousyearsawthehighestpercapitaspendingrecordedsofar.ReadmoreNote(s):SouthKorea;2000to2022Source(s):OECDCHAPTER

03InfrastructureNumberofhealthcareprovidersinSouthKoreafrom2000to2022(in1,000s)NumberofhealthcareprovidersSouthKorea2000-2022120100100.498.4896.7494.8793.1891.5589.9288.1686.6384.9783.8182.9581.6880.2778.4676.880604020075.1172.8270.3967.9665.5562.7161.782000

2001

2002

2003

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

202214Description:In2022,therewerearound100.4thousandhealthcareprovidersinSouthKorea.Whilethisrepresentsanincreasefromthepreviousyear,itwasalsothefirsttimethenumberofprovidersexceeded100thousand.Between2000and2022therewasaroughly62.5percentincreaseinthenumberofactivehealthcareproviders.ReadmoreNote(s):SouthKorea;2000to2022Source(s):HIRA;NHISHospitalbeddensityinSouthKoreafrom2002to2021(per1,000inhabitants)Numberofhospitalbedsper1,000inhabitantsSouthKorea2002-202112.7712.6512.44

12.4312.2911.9911.59

11.6110.9210.259.538.748.197.737.246.485.95.425.094.832002

2003

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

202115Description:TheratioofnumberofhospitalbedsavailabletoinhabitantsinSouthKoreasawnosignificantchangesin2021incomparisontothepreviousyear2020andremainedataround12.77bedsavailableper1,000inhabitants.Still,theratioofnumberofhospitalbedsreacheditshighestvalueintheobservedperiodin2021.ReadmoreNote(s):SouthKorea;2002to2021Source(s):OECDNumberofdoctorsinSouthKoreafrom2000to2021(per1,000inhabitants)Numberofdoctorsper1,000inhabitantsinSouthKorea2000-20212.562.512.462.392.352.292.242.22.162.072.031.981.921.851.731.691.631.571.561.491.391.32000

2001

2002

2003

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

202116Description:In2021,therewereapproximately2.56doctorsforevery1,000inhabitantsinSouthKorea.Thiswasaslightincreasecomparedtotheprecedingyear.Thisratiohasincreasedsteadilysince2000,withtheexceptionofaslightdropin2004.However,SouthKoreastillhasfewdoctorsrelativetoitspopulation.TheOECDaveragewas3.3doctorsper1,000people,andamongthefullOECDmembercountries,onlyMexicoandTurkeyhadlowerratios.AccordingtoOECDdata,keypartnersChina,[...]

ReadmoreNote(s):SouthKorea;2000to2021Source(s):OECDNumberofnursesinSouthKoreafrom2002to2021(per1,000inhabitants)Numberofnursesper1,000inhabitantsinSouthKorea2002-20218.778.377.937.246.956.835.945.575.24.834.714.614.464.324.143.983.843.83.543.432002

2003

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016b

2017

2018

2019

2020

202117Description:TheratioofpracticingnursestoinhabitantsinSouthKoreaincreasedby0.4nursesper1,000inhabitants(+4.78percent)sincethepreviousyear.Whilethegrowthisslowingdown,with8.77nursesper1,000inhabitants,theratioisatitspeakintheobservedperiod.Notably,theratiocontinuouslyincreasedoverthelastyears.ReadmoreNote(s):SouthKorea;2002to2021Source(s):OECDCHAPTER

04StateofhealthLifeexpectancyatbirthinSouthKoreafrom1970to2022(inyears)LifeexpectancyatbirthSouthKorea1970-202285807570656019Description:In2022,theaveragelifeexpectancyatbirthinSouthKoreawas82.7years.Thisrepresentsaslightdecreasecomparedtothepreviousyear.Lifeexpectancyhasincreasedsteadilysince2008,whenitwas80.2years.Overall,womenshowhigherlifeexpectanciesthanmen,adifferenceofaroundsixyears.ReadmoreNote(s):SouthKorea;1970to2022Source(s):StatisticsKoreaObesityrateinSouthKoreafrom2008to2022ObesityrateinSouthKorea2008-202238.3%37.2%37.1%34.8%34.6%34.1%33.8%33.2%32.4%201231.8%201331.4%201131.3%200930.9%201030.9%201430.7%20082015201620172018201920202021202220/statistics/978106/south-korea-obesity-rateIn2022,theoverallobesityrateinSouthKoreastoodat37.2percent.Thiswasthesecondhighestraterecordedsince2008.Obesitywasdefinedashavingabodymassindex(BMI)of25orover.SouthKoreanmenhadahigherobesityratethanwomen.ReadmoreNote(s):SouthKorea;2008to2022;19yearsandolderSource(s):KoreaDiseaseControlandPreventionAgency;StatisticsKoreaMortalityrateinSouthKoreafrom1970to2023(per1,000population)DeathrateSouthKorea1970-20238.58.07.57.06.56.05.55.04.51970

1972

1974

1976

1978

1980

1982

1984

1986

1988

1990

1992

1994

1996

1998

2000

2002

2004

2006

2008

2010

2012

2014

2016

2018

2020

202221/statistics/621091/south-korea-total-death-rateAccordingtoestimates,themortalityrateinSouthKoreawasexpectedtodecreaseto6.9deathsper1,000peoplein2023,from7.3deathsper1,000peopleinthepreviousyear.Themortalityratein2022wasthehighestrecordedinthelast40years.ReadmoreNote(s):SouthKorea;1970to2023;*Preliminary.ReadmoreSource(s):KOSIS;StatisticsKoreaFive-yearsurvivalratesforcancerinSouthKoreainselectedyearsfrom1995to2021Five-yearsurvivalrateforcancerSouthKorea1995-202175%70%65%60%55%72.1%71.6%70.8%65.5%54.2%50%45.2%45%40%35%42.9%199520002005201020152020202122Description:In2021,thefive-yearsurvivalrateforcancerinSouthKoreaincreasedslightlyto72.1percent.Thisisamarkedimprovementfrom1995,wherethesurvivalratewasonly42.9percent.Womenhadabetterchanceofsurvivalthatyear,withasurvivalrateof78.2percent,whilemen'schancesstoodatonly66.1percent.Thefive-yearsurvivalrateisdefinedasthelikelihoodthatacancerpatientwillnotdiefromcancerwithinfiveyearsofstartingtreatment.Ahighrateindicatesthatcancer[...]

ReadmoreNote(s):SouthKorea;1995to2021Source(s):KOSIS;MOHW(SouthKorea)AveragedaysofmedicalcareinstitutionvisitsperpersoninSouthKoreafrom2012to2022MedicalcareinstitutionvisitsperpersonSouthKorea2012-20222521.1920.6120.5720.1620.2919.7119.6319.4219.21201510518.7118.6102012201320142015201620172018201920202021202223Description:In2022,SouthKoreansvisitedmedicalcareinstitutionsanaverageof20.6days.Thisrepresentsareturntopre-pandemicnumbers.Duringthecoronavirus(COVID-19)pandemic,averagevisitshadgonedownslightly,withfactorssuchaslockdowns,fearofcatchingthevirus,andanincreaseinusebasichygienetechniquespotentiallycontributingtothedecreaseinhospitalvisits.ReadmoreNote(s):SouthKorea;2012to2022Source(s):HIRA;NHISCHAPTER

05PublichealthinsurancesystemTotalrevenueofthenationalhealthinsuranceinSouthKoreafrom2011to2022(intrillionSouthKoreanwon)NationalhealthinsurancetotalrevenueSouthKorea2011-20221009091.0181.718075.1169.177062.7258.8256.46605040302010053.2950.5247.2142.4738.7620112012201320142015201620172018201920202021202225Description:In2022,thetotalrevenueofpublichealthinsuranceinSouthKoreawasapproximately91trillionSouthKoreanwon,anincreasefromthepreviousyear.Totalrevenueshaverisensteadilyoverthepastdecade.

ReadmoreNote(s):SouthKorea;2011to2022Source(s):MOHW(SouthKorea);NHISTotalexpenditureofthenationalhealthinsuranceinSouthKoreafrom2011to2022(intrillionSouthKoreanwon)NationalhealthinsurancetotalexpenditureSouthKorea2011-20221009086.1878.958073.6272.17065.9858.02605040302010053.7448.1644.7541.2739.1537.2620112012201320142015201620172018201920202021202226Description:In2022,totalnationalhealthinsurancespendinginSouthKoreaamountedtoabout86.2trillionSouthKoreanwon,upfromabout79trillionwoninthepreviousyear.Theoverallexpenditurehasrisensteadilyoverthepastdecade.

ReadmoreNote(s):SouthKorea;2011to2022Source(s):MOHW(SouthKorea);NHISValueofthenationalhealthinsurancebenefitspaidinSouthKoreafrom2011to2022(intrillionSouthKoreanwon)NationalhealthinsurancebenefitspaidSouthKorea2011-20229080706083.4776.7171.176963.1754.8951.015040302010045.7642.8339.6737.5835.8320112012201320142015201620172018201920202021202227/statistics/978824/south-korea-national-health-insurance-benefits-paidIn2022,thetotalvalueofbenefitspaidbySouthKorea'snationalhealthinsurancewasabout83.5trillionSouthKoreanwon,upfromabout76.7trillionSouthKoreanwoninthepreviousyear.Totalbenefitshaverisensteadilyoverthepastdecade.

ReadmoreNote(s):SouthKorea;2011to2022Source(s):MOHW(SouthKorea);NHISNationalHealthInsurancecontributionspercoveredpersonsinSouthKoreafrom2010to2022(inmillionSouthKoreanwon)NationalHealthInsurancecontributionpercapitaSouthKorea2010-20221.81.61.71.541.411.41.21.00.80.60.40.20.01.311.21.121.081.020.960.90.840.770.68201020112012201320142015201620172018201920202021202228Description:In2022,theNationalHealthInsurancecontributionpercapitaamountedtoaround1.7millionSouthKoreanwon,upfromaround1.54millionSouthKoreanwoninthepreviousyear.Annualcontributionsperinsuredpersonhaverisensteadilyinrecentyears.ReadmoreNote(s):SouthKorea;2010to2022Source(s):HIRA;NHISNationalHealthInsurancebenefitspaidpercoveredpersonsinSouthKoreafrom2010to2022(inmillionSouthKoreanwon)NationalHealthInsurancebenefitspercapitaSouthKorea2010-20221.81.61.621.491.391.351.41.21.00.80.60.40.20.01.241.081.010.910.850.80.760.730.69201020112012201320142015201620172018201920202021202229Description:In2022,theNationalHealthInsurancebenefitspercapitaamountedtoaround1.62millionSouthKoreanwon,upfromaround1.5millionwoninthepreviousyear.Annualbenefitsperinsuredpersonhaveincreasedsteadilyinrecentyears.

ReadmoreNote(s):SouthKorea;2010to2022Source(s):HIRA;NHISCHAPTER

06ForeignpatientsDistributionofforeignpatientstravelingtoSouthKoreaformedicaltreatmentin2023,bycountryoforiginMedicaltouristsinSouthKoreain2023,bycountryoforiginShareofpatients15%0%5%10%20%25%30%JapanChina31%18.5%USA12.7%ThailandMongoliaVietnamRussia5.1%3.6%3.4%2.4%2.2%SingaporeTaiwan2.1%KazakhstanCanadaAustraliaIndonesiaOthers1.9%1.5%1.1%1.1%13.3%31Description:AmedicaltouristisdefinedbytheWorldHealthOrganization(WHO)asapersonwhotravelsacrossinternationalborderstoreceivesomeformofmedicaltreatment,mostcommonlydentalcare,cosmeticsurgery,andfertilitytreatments.JapanesemadeupthelargestshareofmedicaltouriststoSouthKoreain2023,ataround31percentofinboundtourists,followedbymainlandChinesetourists.Thenumberofpatientsfromallcountriesrecordedthehighesteversince,afterrecovering[...]

ReadmoreNote(s):SouthKorea;2023Source(s):KHIDIDistributionofforeignpatientstravelingtoSouthKoreaformedicaltreatmentin2023,bydepartmentDistributionofmedicaltouristsinSouthKoreain2023,bydepartmentDistributionofpatients15%0%5%10%20%25%30%35%35.2%DermatologyPlasticsurgery16.8%InternalmedicineMedicalexaminationcenterOrientalMedicineDentistry13.4%7.4%2.7%2.3%Orthopedics2.3%2.1%2.1%2%ObstetricsandgynecologyGeneralSurgeryOphthalmologyPediatrics1.4%Others12.2%32Description:In2023,around35.2percentofforeignerswhocametoSouthKoreaasmedicaltouristsreceivedmedicaltreatmentsatdepartmentsfordermatology.Thiswasfollowedbyplasticsurgeryandinternalmedicine,at16.8percentand13.4percentofforeignpatientsrespectively.ThetotalnumberofmedicaltouriststoSouthKorearecordedthehighestthatyear.ꢀReasonsforinboundmedicaltourisminSouthKoreaSouthKoreaisapopulardestinationformedicaltourismsinceitoffers[...]

ReadmoreNote(s):SouthKorea;2023;patientswithmultipletreatmentswerecountedasoneSource(s):KHIDINumberofforeignpatientswhovisitedinternalmedicinedepartmentinSouthKoreafrom2012to2023(in1,000s)NumberofforeignpatientsatinternalmedicinedepartmentSouthKorea2012-2023120100113.4490.9689.9885.0880.5179.3879.0980604020068.4565.4247.9345.9929.0920202012201320142015201620172018201920212022202333Description:In2023,therewereover90thousandforeignpatientswhovisitedtheinternalmedicinedepartmentinSouthKorea,anincreasefromthepreviousyear,thoughstillbelowpre-COVID-19pandemicfigures.Thatyear,patientsfromJapanandChinamadeupthelargestꢀproportionofallmedicaltouriststoSouthKorea.ReadmoreNote(s):SouthKorea;2012to2023;patientwithmultipletreatmentsiscountedasoneSource(s):KHIDINumberofforeignpatientswhovisitedplasticandcosmeticsurgerydepartmentsinSouthKoreafrom2009to2023Foreignplast